Skip to content
Friday, November 13, 2026
ZoneFuture UK

Zimbabwe Rejects ‘Lopsided’ US Health Aid Agreement Over Information Concerns

Medical funding image
The proposed US funding was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (£272m) over five years over the United States' insistence on sensitive biological samples.

This rejection became public after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".

An official representative later clarified that the United States was demanding access to health data for research and profit but was not willing to share the benefits from future vaccines.

"We must now begin the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has urged further dialogue to secure a agreement agreeable to both sides so the nation's vital HIV programme can continue.

Broader Background

This rejection follows a comparable case in Kenya, where a court blocked a similar deal with the US following concerns were raised about the safety of Kenyans' health data.

After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government deals to boost openness and responsibility.

According to statements, 16 nations in Africa have so far signed similar health pacts, representing more than $18.3bn in committed funds.

Specifics of the Rejected Agreement

This assistance for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this partnership might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont commented.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"Our nation was requested to provide its biological resources and data indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.

"Put simply, our nation would provide the basic resources for scientific discovery with no assurance that the end products would be available to our population if a future disease outbreak arise."

National Interest and Global Health

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures already set up through the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.

"This system is designed to guarantee that when a country provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to create them."

The government's concerns over the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We are open to continued dialogue with our American counterparts on how future co-operation could be arranged in a way that respects the independence and dignity of each country."

Medical Community Reaction

A leading public health body stated it recognised the official position, but suggested that talks should continue considering a large portion of the country's HIV programmes relied on external financing.

"In cases where technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," the group said.

The halted deal underscores the ongoing challenges between receiving vital international aid and safeguarding local interests in an increasingly interconnected world.

By

Karen Jones

A tech futurist and innovation strategist based in London, focusing on emerging technologies and their societal impacts.

ZoneFuture UK

Type to search articles.